LMG Life Sciences Awards EMEA 2024: open for nominations

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Awards EMEA 2024: open for nominations

lmg life sciences awards emea subs open.png

The EMEA region research cycle has commenced - do not miss this opportunity to nominate your work from 2023!

The EMEA region research cycle has commenced – do not miss this opportunity to nominate your work from 2023!

The LMG Life Sciences is excited to announced the launch of the 2024 research. We continue to recognise the top firms, lawyers, and legal work serving the Life Sciences industry from throughout the Europe, Middle East, & Africa region.

The deadline for nominations is 25 January 2024.

You can find detailed information about the awards by downloading the methodology, or reading the FAQs and the full list of categories on the LMG Life Sciences website.

Important Dates:

Nominations Open

Nominations Close

Shortlist Published

Gala Ceremony

8 December 2023

25 January 2024

March 2024

May 2024


All nominations to the awards must be entered through our dedicated nomination gateway. Nominations made in any other format or emailed to us will not be accepted.

For any questions about the awards or the research, please contact research editor, John Harrison.

For queries about business development and commercial opportunities, please contact George Reeves.

LMG Life Sciences Awards

The LMG Life Sciences awards look to recognise leading law firms and lawyers specialised in the life sciences industry throughout the Europe, Middle East, and Africa region. The awards ceremony will take place to celebrate outstanding legal work over the previous calendar year. The awards ceremony aims to honour firms and attorneys on the forefront of legal work in life sciences. The award’s distinctive structure highlights firms that specialise in practice areas within the life sciences industry by shortlisting firms and by listing our life sciences nominees in a way that shows overlap between certain legal areas.


Please note that LMG Life Sciences is a sister publication to and supported by Managing IP but run independently to the IP Stars research.

more from across site and ros bottom lb

More from across our site

A decision by the Paris Central Division will lead to more IP work for outside counsel, say sources
Courts are encouraged to deliver judgments within three months of a trial, but that deadline has been missed in several recent cases
Lawyers at Maiwald and Sterne Kessler analyse how patents with claims directed to medical treatments are handled in the US and in Europe
Michael DeVincenzo explains how he and his team convinced the Federal Circuit to find in favour of his client in a patent case against Salesforce
Funders and a litigator explain how litigation funding disclosure requirements could affect their business
We provide a rundown of Managing IP’s news and analysis from the week, and review what’s been happening elsewhere in IP
Discussions about whether to seek director reviews can come up frequently with clients, even though actual grant rates are rare
In the latest episode, we discuss why IP firms might be attractive to PE investors and bring you the latest news on submissions for next year’s IP STARS rankings
Back-to-back PE deals for IP firms in recent years show that IP firms are sitting on goldmines, so traditional partnerships should be open to change
Joseph Maraia, whose team left Burns & Levinson shortly before it closed, says ArentFox Schiff is looking at the right opportunities
Gift this article